Effect of olanzapine for breast cancer patients resistant to triplet antiemetic therapy with nausea due to anthracycline-containing adjuvant chemotherapy

Triplet antiemetic therapy with neurokinin 1 receptor blocker, 5-hydroxytryptamine receptor blocker and steroids is commonly used in patients who are highly emetic after chemotherapy. However, an alternative antiemetic therapy for patients who are resistant to triplet antiemetic therapy is not estab...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of clinical oncology 2016-05, Vol.46 (5), p.415-420
Hauptverfasser:	Sato, Junya, Kashiwaba, Masahiro, Komatsu, Hideaki, Ishida, Kazushige, Nihei, Satoru, Kudo, Kenzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Anthracyclines - adverse effects Anthracyclines - therapeutic use Antiemetics - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Benzodiazepines - adverse effects Benzodiazepines - therapeutic use Breast Neoplasms - drug therapy Chemotherapy, Adjuvant Drug Resistance, Neoplasm Drug Therapy, Combination Female Humans Middle Aged Nausea - etiology Severity of Illness Index Vomiting - etiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!